Literature DB >> 10482909

Differentiated effects on splanchnic homeostasis by selective and non-selective endothelin receptor antagonism in porcine endotoxaemia.

A Oldner1, M Wanecek, E Weitzberg, P Sundin, A Sollevi, C Rubio, P M Hellström, K Alving, A Rudehill.   

Abstract

1. The non-selective endothelin (ET) receptor antagonist bosentan has been shown to restore systemic and gut oxygen delivery and reverse intestinal mucosal acidosis in porcine endotoxin shock. 2. To further elucidate the specific role of the ETA as opposed to the ETB receptor and their effects in the splanchnic region a non-selective (ET(MIX)ra) A-182086 and selective ETA (ET(A)ra) PD155080 and ETB (ET(B)ra) A-192621 receptor antagonists were administered, separately or simultaneously (ET(A+B)ra) 2 h after onset of endotoxin shock. These four groups were compared to a control group receiving only endotoxin and vehicle. 3. Thirty-nine pigs were anaesthetized and catheterized for measurement of central and regional haemodynamics. A tonometer in the distal ileum was used for measurement of mucosal PCO2. Blood gases and plasma ET-1-LI levels as well as histological samples from the gut were assessed. Intervention was started 2 h after onset of endotoxemia and the experiments were terminated after 5 h. 4. Endotoxin-induced changes in systemic, gut oxygen delivery and portal hepatic vascular resistance and systemic acidosis were effectively counteracted by both ET(A+B)ra an ET(MIX)ra. ET(A)ra administration was not effective while ET(B)ra proved to be fatal as all animals in this group died prior to full time of the experiment. While both ET(A+B)ra and ET(MIX)ra improved gut oxygen delivery only the latter attenuated the profound endotoxin-induced ileal mucosal acidosis. 5. The lethal effect seen from selective ETB receptor antagonism in the current study may be due to increased ETA receptor activity as plasma levels of ET-1 is increased several fold by blocking the ETB receptor and thereby the plasma-ET-1-clearing function. Furthermore, a loss of endothelial ETB receptor vasodilating properties may also have contributed to the lethal course in the ET(B)ra group. 6. The findings in this study suggest that ET is involved in the profound endotoxin-induced disturbances in splanchnic homeostasis in porcine endotoxaemia. Furthermore, antagonism of both ETA and ETB receptors is necessary to effectively counteract these changes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10482909      PMCID: PMC1566181          DOI: 10.1038/sj.bjp.0702736

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  59 in total

1.  Coexpression studies with endothelin receptor subtypes indicate the existence of intracellular cross-talk between ET(A) and ET(B) receptors.

Authors:  S Ozaki; K Ohwaki; M Ihara; K Ishikawa; M Yano
Journal:  J Biochem       Date:  1997-03       Impact factor: 3.387

2.  Pulmonary clearance of circulating endothelin-1 in dogs in vivo: exclusive role of ETB receptors.

Authors:  J Dupuis; C A Goresky; A Fournier
Journal:  J Appl Physiol (1985)       Date:  1996-10

3.  Elevated plasma endothelin-1 concentrations are associated with the severity of illness in patients with sepsis.

Authors:  J F Pittet; D R Morel; A Hemsen; K Gunning; J S Lacroix; P M Suter; J M Lundberg
Journal:  Ann Surg       Date:  1991-03       Impact factor: 12.969

4.  Cloning and expression of a cDNA encoding an endothelin receptor.

Authors:  H Arai; S Hori; I Aramori; H Ohkubo; S Nakanishi
Journal:  Nature       Date:  1990 Dec 20-27       Impact factor: 49.962

5.  Endothelin-1 induces liver vasoconstriction through both ETA and ETB receptors.

Authors:  B Zhang; Y Calmus; L Wen; P Sogni; S Lotersztajn; D Houssin; B Weill
Journal:  J Hepatol       Date:  1997-05       Impact factor: 25.083

6.  An orally active non-selective endothelin receptor antagonist, bosentan, markedly reduces injury in a rat model of colitis.

Authors:  C M Hogaboam; M J Muller; S M Collins; R H Hunt
Journal:  Eur J Pharmacol       Date:  1996-08-15       Impact factor: 4.432

7.  Elevated plasma levels of endothelin in patients with sepsis syndrome.

Authors:  E Weitzberg; J M Lundberg; A Rudehill
Journal:  Circ Shock       Date:  1991-04

8.  Cardiopulmonary dysfunction during porcine endotoxin shock is effectively counteracted by the endothelin receptor antagonist bosentan.

Authors:  M Wanecek; A Oldner; A Rudehill; A Sollevi; K Alving; E Weitzberg
Journal:  Shock       Date:  1997-05       Impact factor: 3.454

9.  Improved method for quantification of tissue PMN accumulation measured by myeloperoxidase activity.

Authors:  C Schierwagen; A C Bylund-Fellenius; C Lundberg
Journal:  J Pharmacol Methods       Date:  1990-05

10.  A time-dependent balance between endothelins and nitric oxide regulating portal resistance after endotoxin.

Authors:  B H Pannen; M Bauer; J X Zhang; J L Robotham; M G Clemens
Journal:  Am J Physiol       Date:  1996-11
View more
  3 in total

1.  The role of endothelium and endogenous vasoactive substances in sepsis.

Authors:  G Kotsovolis; K Kallaras
Journal:  Hippokratia       Date:  2010-04       Impact factor: 0.471

2.  Effects of the novel selective endothelin ET(A) receptor antagonist, SB 234551, on the cardiovascular responses to endotoxaemia in conscious rats.

Authors:  S M Gardiner; J E March; P A Kemp; T Bennett
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

3.  Endothelin receptor A antagonism attenuates renal medullary blood flow impairment in endotoxemic pigs.

Authors:  Johan Fenhammar; Andreas Andersson; Jakob Forestier; Eddie Weitzberg; Alf Sollevi; Hans Hjelmqvist; Robert Frithiof
Journal:  PLoS One       Date:  2011-07-08       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.